Benzinga's Top Upgrades - Alimera Sciences (NASDAQ:ALIM)

Goldman Sachs upgraded Comerica Incorporated CMA from Neutral to Buy. Comerica shares gained 1.24 percent to $47.24 in pre-market trading.
Analysts at Wells Fargo upgraded C R Bard Inc BCR from Market Perform to Outperform. C.R. Bard shares rose 3.18 percent to close at $223.63 on Thursday.
Atlantic Equities upgraded Clorox Co CLX from Hold to Buy. Clorox shares rose 0.02 percent to close at $122.54 on Thursday.
Edward Jones upgraded Hormel Foods Corp HRL from Hold to Buy. Hormel shares rose 0.74 percent to $36.95 in pre-market trading.
Analysts at Desjardins upgraded DexCom, Inc. DXCM from Hold to Buy. DexCom shares rose 1.05 percent to close at $92.75 on Thursday.
Tudor Pickering upgraded Energen Corporation EGN from Hold to Buy. Energen shares rose 0.23 percent to close at $52.31 on Thursday.
Analysts at Keefe Bruyette & Woods upgraded Progressive Corp PGR from Underperform to Market Perform. Progressive shares rose 1.04 percent to close at $31.09 on Thursday.
Bank of America upgraded Statoil ASA(ADR) STO from Neutral to Buy. Statoil shares rose 0.26 percent to $15.22 in pre-market trading.
Analysts at Cowen & Co. upgraded Alimera Sciences Inc ALIM from Market Perform to Outperform. Alimera Sciences shares gained 7.89 percent to $1.64 in pre-market trading.
Barclays upgraded IHS Markit Ltd INFO from Neutral to Outperform. IHS Markit shares rose 0.38 percent to close at $36.51 on Thursday.